Global Point-Of-Care Or Rapid Diagnostics Market Growth 2024-2030

The Point-Of-Care Or Rapid Diagnostics market, valued at $25.11 billion in 2023, is estimated to grow to $48.17 billion by 2030, fueled by increasing demand in downstream markets a

In the realm of healthcare, timely diagnosis is paramount. Traditional diagnostic methods often involve sending samples to laboratories, leading to delays in results and impacting treatment decisions. The global point-of-care (POC) diagnostics market emerges as a game-changer, offering rapid and convenient diagnostic testing at the point of care - often right at a doctor's office, clinic, or even in the home. POC tests are compact, user-friendly devices that deliver test results in minutes, empowering healthcare professionals with the ability to: • Diagnose illnesses quickly: This allows for earlier intervention and treatment initiation, potentially improving patient outcomes. For instance, a rapid strep test at a doctor's visit can confirm a strep throat infection, eliminating the need for unnecessary antibiotics. • Improve Patient Experience: POC tests eliminate the need for lengthy waits for lab results, reducing patient anxiety and improving overall experience. • Enhance Accessibility: POC testing can be particularly beneficial in remote areas or resource-limited settings where access to traditional laboratory facilities might be limited. According to our publisher’s latest study, the global Point-Of-Care Or Rapid Diagnostics market size was valued at US$ 25110 million in 2023. With growing demand in downstream market, the Point-Of-Care Or Rapid Diagnostics is forecast to a readjusted size of US$ 48170 million by 2030 with a CAGR of 9.8% during review period.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

The research report highlights the growth potential of the global Point-Of-Care Or Rapid Diagnostics market. Point-Of-Care Or Rapid Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Point-Of-Care Or Rapid Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Point-Of-Care Or Rapid Diagnostics market. Point-of-care testing (POCT or bedside testing) is defined as medical diagnostic testing at or near the point of care—that is, at the time and place of patient care. In our report, blood glucose test strips and blood glucose meter, which mainly used at home, are not included. In Spain & Portugal Market, Oint-of-Care or Rapid Diagnostics key players include, Roche, Abbott, Danaher, Siemens Healthcare, Bio-Rad Laboratories, etc. Top 5 manufacturers hold a share over 74%. In terms of product, Intensive Care is the largest segment, with a share over 19%. And in terms of application, the largest application is Hospital, followed by Clinic, Independent Laboratories and Others.

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

Key Features: The report on Point-Of-Care Or Rapid Diagnostics market reflects various aspects and provide valuable insights into the industry. Market Size and Growth: The research report provide an overview of the current size and growth of the Point-Of-Care Or Rapid Diagnostics market. It may include historical data, market segmentation by Type (e.g., Intensive Care, Covid-19 Testing), and regional breakdowns. Point-of-Care Diagnostics Market: A Snapshot •

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Point-Of-Care Or Rapid Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs. Market Drivers: • Rising Burden of Chronic Disease: The growing prevalence of chronic conditions like diabetes and heart disease fuels demand for convenient and regular monitoring using POC tests. • Decentralized Healthcare Shift: The trend towards care delivery outside hospitals necessitates readily available diagnostic tools, making POC testing a prime candidate. Market Trends: • Tech Advancements: Continuous improvements in microfluidics and biosensors lead to more sophisticated, accurate, and user-friendly POC tests. • Telehealth Integration: POC tests are increasingly being integrated with telehealth platforms, enabling remote patient monitoring and improved care coordination. Market Challenges: • Cost Considerations: High upfront costs for POC devices and test cartridges can limit their widespread adoption in resource-limited settings. Competitive Landscape: The research report provides analysis of the competitive landscape within the Point-Of-Care Or Rapid Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market. Technological Developments: The research report can delve into the latest technological developments in the Point-Of-Care Or Rapid Diagnostics industry. This include advancements in Point-Of-Care Or Rapid Diagnostics technology, Point-Of-Care Or Rapid Diagnostics new entrants, Point-Of-Care Or Rapid Diagnostics new investment, and other innovations that are shaping the future of Point-Of-Care Or Rapid Diagnostics. • Microfluidics Power: Miniaturized fluid handling systems enable complex tests on smaller, portable devices, making POC testing even more convenient. • Biosensor Breakthroughs: Advanced biosensors with improved sensitivity and specificity will lead to more accurate and reliable POC test results. • Connectivity on the Rise: Integration with smartphones and telemedicine platforms will allow for real-time data sharing, remote diagnostics, and improved patient management. Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Point-Of-Care Or Rapid Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Point-Of-Care Or Rapid Diagnostics product. Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Point-Of-Care Or Rapid Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Point-Of-Care Or Rapid Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth. Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Point-Of-Care Or Rapid Diagnostics market. Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Point-Of-Care Or Rapid Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments. • Multiplex Testing Capabilities: Development of POC tests capable of detecting multiple diseases or conditions simultaneously can improve efficiency and provide a more comprehensive health picture. • Connectivity and Telehealth: Connecting POC devices to healthcare networks can facilitate remote consultations, specialist intervention, and real-time data sharing for improved patient management. • Home Testing Boom: Advancements in user-friendliness and affordability will likely lead to a surge in home-based POC testing, empowering patients to take a more active role in their health monitoring. Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Point-Of-Care Or Rapid Diagnostics market. • Chronic Disease Management: Develop POC tests for monitoring conditions like diabetes and heart disease, empowering patients for self-care and improving clinical decision-making. • Decentralized Healthcare Hero: Cater to the growing trend of home-based and remote care with user-friendly POC tests for various health concerns. • Emerging Markets Access: Make POC diagnostics more affordable and accessible in developing regions with limited lab infrastructure. Market Segmentation: Point-Of-Care Or Rapid Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. Segmentation by type Intensive Care Covid-19 Testing Infectious Diseases Testing Cardiac Markers Testing Coagulation Testing Others Segmentation by application Hospital Clinic Independent Laboratories Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Roche Abbott Danaher Siemens Healthcare Bio-Rad Laboratories BioMerieux Nova Biomedical Thermo Fisher Scientific Quidel A. Menarini Diagnostics Becton Dickinson Biosurfit Astrego Diagnostics Werfen Abionic Palex Medical/Bülhmann Horiba Medical RAL Vircell Monlab Binding Site

Table of Contents

  • 1 Scope of the Report
  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats
  • 2 Executive Summary
  • 2.1 World Market Overview
  • 2.1.1 Global Point-Of-Care Or Rapid Diagnostics Annual Sales 2019-2030
  • 2.1.2 World Current & Future Analysis for Point-Of-Care Or Rapid Diagnostics by Geographic Region, 2019, 2023 & 2030
  • 2.1.3 World Current & Future Analysis for Point-Of-Care Or Rapid Diagnostics by Country/Region, 2019, 2023 & 2030
  • 2.2 Point-Of-Care Or Rapid Diagnostics Segment by Type
  • 2.2.1 Intensive Care
  • 2.2.2 Covid-19 Testing
  • 2.2.3 Infectious Diseases Testing
  • 2.2.4 Cardiac Markers Testing
  • 2.2.5 Coagulation Testing
  • 2.2.6 Others
  • 2.3 Point-Of-Care Or Rapid Diagnostics Sales by Type
  • 2.3.1 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2019-2024)
  • 2.3.2 Global Point-Of-Care Or Rapid Diagnostics Revenue and Market Share by Type (2019-2024)
  • 2.3.3 Global Point-Of-Care Or Rapid Diagnostics Sale Price by Type (2019-2024)
  • 2.4 Point-Of-Care Or Rapid Diagnostics Segment by Application
  • 2.4.1 Hospital
  • 2.4.2 Clinic
  • 2.4.3 Independent Laboratories
  • 2.4.4 Others
  • 2.5 Point-Of-Care Or Rapid Diagnostics Sales by Application
  • 2.5.1 Global Point-Of-Care Or Rapid Diagnostics Sale Market Share by Application (2019-2024)
  • 2.5.2 Global Point-Of-Care Or Rapid Diagnostics Revenue and Market Share by Application (2019-2024)
  • 2.5.3 Global Point-Of-Care Or Rapid Diagnostics Sale Price by Application (2019-2024)
  • 3 Global Point-Of-Care Or Rapid Diagnostics by Company
  • 3.1 Global Point-Of-Care Or Rapid Diagnostics Breakdown Data by Company
  • 3.1.1 Global Point-Of-Care Or Rapid Diagnostics Annual Sales by Company (2019-2024)
  • 3.1.2 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Company (2019-2024)
  • 3.2 Global Point-Of-Care Or Rapid Diagnostics Annual Revenue by Company (2019-2024)
  • 3.2.1 Global Point-Of-Care Or Rapid Diagnostics Revenue by Company (2019-2024)
  • 3.2.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Company (2019-2024)
  • 3.3 Global Point-Of-Care Or Rapid Diagnostics Sale Price by Company
  • 3.4 Key Manufacturers Point-Of-Care Or Rapid Diagnostics Producing Area Distribution, Sales Area, Product Type
  • 3.4.1 Key Manufacturers Point-Of-Care Or Rapid Diagnostics Product Location Distribution
  • 3.4.2 Players Point-Of-Care Or Rapid Diagnostics Products Offered
  • 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Point-Of-Care Or Rapid Diagnostics by Geographic Region
  • 4.1 World Historic Point-Of-Care Or Rapid Diagnostics Market Size by Geographic Region (2019-2024)
  • 4.1.1 Global Point-Of-Care Or Rapid Diagnostics Annual Sales by Geographic Region (2019-2024)
  • 4.1.2 Global Point-Of-Care Or Rapid Diagnostics Annual Revenue by Geographic Region (2019-2024)
  • 4.2 World Historic Point-Of-Care Or Rapid Diagnostics Market Size by Country/Region (2019-2024)
  • 4.2.1 Global Point-Of-Care Or Rapid Diagnostics Annual Sales by Country/Region (2019-2024)
  • 4.2.2 Global Point-Of-Care Or Rapid Diagnostics Annual Revenue by Country/Region (2019-2024)
  • 4.3 Americas Point-Of-Care Or Rapid Diagnostics Sales Growth
  • 4.4 APAC Point-Of-Care Or Rapid Diagnostics Sales Growth
  • 4.5 Europe Point-Of-Care Or Rapid Diagnostics Sales Growth
  • 4.6 Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales Growth
  • 5 Americas
  • 5.1 Americas Point-Of-Care Or Rapid Diagnostics Sales by Country
  • 5.1.1 Americas Point-Of-Care Or Rapid Diagnostics Sales by Country (2019-2024)
  • 5.1.2 Americas Point-Of-Care Or Rapid Diagnostics Revenue by Country (2019-2024)
  • 5.2 Americas Point-Of-Care Or Rapid Diagnostics Sales by Type
  • 5.3 Americas Point-Of-Care Or Rapid Diagnostics Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil
  • 6 APAC
  • 6.1 APAC Point-Of-Care Or Rapid Diagnostics Sales by Region
  • 6.1.1 APAC Point-Of-Care Or Rapid Diagnostics Sales by Region (2019-2024)
  • 6.1.2 APAC Point-Of-Care Or Rapid Diagnostics Revenue by Region (2019-2024)
  • 6.2 APAC Point-Of-Care Or Rapid Diagnostics Sales by Type
  • 6.3 APAC Point-Of-Care Or Rapid Diagnostics Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan
  • 7 Europe
  • 7.1 Europe Point-Of-Care Or Rapid Diagnostics by Country
  • 7.1.1 Europe Point-Of-Care Or Rapid Diagnostics Sales by Country (2019-2024)
  • 7.1.2 Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country (2019-2024)
  • 7.2 Europe Point-Of-Care Or Rapid Diagnostics Sales by Type
  • 7.3 Europe Point-Of-Care Or Rapid Diagnostics Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia
  • 8 Middle East & Africa
  • 8.1 Middle East & Africa Point-Of-Care Or Rapid Diagnostics by Country
  • 8.1.1 Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Country (2019-2024)
  • 8.1.2 Middle East & Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country (2019-2024)
  • 8.2 Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Type
  • 8.3 Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis
  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Point-Of-Care Or Rapid Diagnostics
  • 10.3 Manufacturing Process Analysis of Point-Of-Care Or Rapid Diagnostics
  • 10.4 Industry Chain Structure of Point-Of-Care Or Rapid Diagnostics
  • 11 Marketing, Distributors and Customer
  • 11.1 Sales Channel
  • 11.1.1 Direct Channels
  • 11.1.2 Indirect Channels
  • 11.2 Point-Of-Care Or Rapid Diagnostics Distributors
  • 11.3 Point-Of-Care Or Rapid Diagnostics Customer
  • 12 World Forecast Review for Point-Of-Care Or Rapid Diagnostics by Geographic Region
  • 12.1 Global Point-Of-Care Or Rapid Diagnostics Market Size Forecast by Region
  • 12.1.1 Global Point-Of-Care Or Rapid Diagnostics Forecast by Region (2025-2030)
  • 12.1.2 Global Point-Of-Care Or Rapid Diagnostics Annual Revenue Forecast by Region (2025-2030)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Point-Of-Care Or Rapid Diagnostics Forecast by Type
  • 12.7 Global Point-Of-Care Or Rapid Diagnostics Forecast by Application
  • 13 Key Players Analysis
  • 13.1 Roche
  • 13.1.1 Roche Company Information
  • 13.1.2 Roche Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
  • 13.1.3 Roche Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.1.4 Roche Main Business Overview
  • 13.1.5 Roche Latest Developments
  • 13.2 Abbott
  • 13.2.1 Abbott Company Information
  • 13.2.2 Abbott Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
  • 13.2.3 Abbott Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.2.4 Abbott Main Business Overview
  • 13.2.5 Abbott Latest Developments
  • 13.3 Danaher
  • 13.3.1 Danaher Company Information
  • 13.3.2 Danaher Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
  • 13.3.3 Danaher Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.3.4 Danaher Main Business Overview
  • 13.3.5 Danaher Latest Developments
  • 13.4 Siemens Healthcare
  • 13.4.1 Siemens Healthcare Company Information
  • 13.4.2 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
  • 13.4.3 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.4.4 Siemens Healthcare Main Business Overview
  • 13.4.5 Siemens Healthcare Latest Developments
  • 13.5 Bio-Rad Laboratories
  • 13.5.1 Bio-Rad Laboratories Company Information
  • 13.5.2 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
  • 13.5.3 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.5.4 Bio-Rad Laboratories Main Business Overview
  • 13.5.5 Bio-Rad Laboratories Latest Developments
  • 13.6 BioMerieux
  • 13.6.1 BioMerieux Company Information
  • 13.6.2 BioMerieux Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
  • 13.6.3 BioMerieux Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.6.4 BioMerieux Main Business Overview
  • 13.6.5 BioMerieux Latest Developments
  • 13.7 Nova Biomedical
  • 13.7.1 Nova Biomedical Company Information
  • 13.7.2 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
  • 13.7.3 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.7.4 Nova Biomedical Main Business Overview
  • 13.7.5 Nova Biomedical Latest Developments
  • 13.8 Thermo Fisher Scientific
  • 13.8.1 Thermo Fisher Scientific Company Information
  • 13.8.2 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
  • 13.8.3 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.8.4 Thermo Fisher Scientific Main Business Overview
  • 13.8.5 Thermo Fisher Scientific Latest Developments
  • 13.9 Quidel
  • 13.9.1 Quidel Company Information
  • 13.9.2 Quidel Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
  • 13.9.3 Quidel Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.9.4 Quidel Main Business Overview
  • 13.9.5 Quidel Latest Developments
  • 13.10 A. Menarini Diagnostics
  • 13.10.1 A. Menarini Diagnostics Company Information
  • 13.10.2 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
  • 13.10.3 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.10.4 A. Menarini Diagnostics Main Business Overview
  • 13.10.5 A. Menarini Diagnostics Latest Developments
  • 13.11 Becton Dickinson
  • 13.11.1 Becton Dickinson Company Information
  • 13.11.2 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
  • 13.11.3 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.11.4 Becton Dickinson Main Business Overview
  • 13.11.5 Becton Dickinson Latest Developments
  • 13.12 Biosurfit
  • 13.12.1 Biosurfit Company Information
  • 13.12.2 Biosurfit Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
  • 13.12.3 Biosurfit Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.12.4 Biosurfit Main Business Overview
  • 13.12.5 Biosurfit Latest Developments
  • 13.13 Astrego Diagnostics
  • 13.13.1 Astrego Diagnostics Company Information
  • 13.13.2 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
  • 13.13.3 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.13.4 Astrego Diagnostics Main Business Overview
  • 13.13.5 Astrego Diagnostics Latest Developments
  • 13.14 Werfen
  • 13.14.1 Werfen Company Information
  • 13.14.2 Werfen Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
  • 13.14.3 Werfen Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.14.4 Werfen Main Business Overview
  • 13.14.5 Werfen Latest Developments
  • 13.15 Abionic
  • 13.15.1 Abionic Company Information
  • 13.15.2 Abionic Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
  • 13.15.3 Abionic Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.15.4 Abionic Main Business Overview
  • 13.15.5 Abionic Latest Developments
  • 13.16 Palex Medical/Bülhmann
  • 13.16.1 Palex Medical/Bülhmann Company Information
  • 13.16.2 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
  • 13.16.3 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.16.4 Palex Medical/Bülhmann Main Business Overview
  • 13.16.5 Palex Medical/Bülhmann Latest Developments
  • 13.17 Horiba Medical
  • 13.17.1 Horiba Medical Company Information
  • 13.17.2 Horiba Medical Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
  • 13.17.3 Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.17.4 Horiba Medical Main Business Overview
  • 13.17.5 Horiba Medical Latest Developments
  • 13.18 RAL
  • 13.18.1 RAL Company Information
  • 13.18.2 RAL Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
  • 13.18.3 RAL Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.18.4 RAL Main Business Overview
  • 13.18.5 RAL Latest Developments
  • 13.19 Vircell
  • 13.19.1 Vircell Company Information
  • 13.19.2 Vircell Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
  • 13.19.3 Vircell Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.19.4 Vircell Main Business Overview
  • 13.19.5 Vircell Latest Developments
  • 13.20 Monlab
  • 13.20.1 Monlab Company Information
  • 13.20.2 Monlab Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
  • 13.20.3 Monlab Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.20.4 Monlab Main Business Overview
  • 13.20.5 Monlab Latest Developments
  • 13.21 Binding Site
  • 13.21.1 Binding Site Company Information
  • 13.21.2 Binding Site Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
  • 13.21.3 Binding Site Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.21.4 Binding Site Main Business Overview
  • 13.21.5 Binding Site Latest Developments
  • 14 Research Findings and Conclusion

List of Tables
Table 1. Point-Of-Care Or Rapid Diagnostics Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Point-Of-Care Or Rapid Diagnostics Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Intensive Care
Table 4. Major Players of Covid-19 Testing
Table 5. Major Players of Infectious Diseases Testing
Table 6. Major Players of Cardiac Markers Testing
Table 7. Major Players of Coagulation Testing
Table 8. Major Players of Others
Table 9. Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2019-2024) & (K Doses)
Table 10. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2019-2024)
Table 11. Global Point-Of-Care Or Rapid Diagnostics Revenue by Type (2019-2024) & ($ million)
Table 12. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type (2019-2024)
Table 13. Global Point-Of-Care Or Rapid Diagnostics Sale Price by Type (2019-2024) & (US$/Dose)
Table 14. Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2019-2024) & (K Doses)
Table 15. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2019-2024)
Table 16. Global Point-Of-Care Or Rapid Diagnostics Revenue by Application (2019-2024)
Table 17. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application (2019-2024)
Table 18. Global Point-Of-Care Or Rapid Diagnostics Sale Price by Application (2019-2024) & (US$/Dose)
Table 19. Global Point-Of-Care Or Rapid Diagnostics Sales by Company (2019-2024) & (K Doses)
Table 20. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Company (2019-2024)
Table 21. Global Point-Of-Care Or Rapid Diagnostics Revenue by Company (2019-2024) ($ Millions)
Table 22. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Company (2019-2024)
Table 23. Global Point-Of-Care Or Rapid Diagnostics Sale Price by Company (2019-2024) & (US$/Dose)
Table 24. Key Manufacturers Point-Of-Care Or Rapid Diagnostics Producing Area Distribution and Sales Area
Table 25. Players Point-Of-Care Or Rapid Diagnostics Products Offered
Table 26. Point-Of-Care Or Rapid Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Point-Of-Care Or Rapid Diagnostics Sales by Geographic Region (2019-2024) & (K Doses)
Table 30. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share Geographic Region (2019-2024)
Table 31. Global Point-Of-Care Or Rapid Diagnostics Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global Point-Of-Care Or Rapid Diagnostics Sales by Country/Region (2019-2024) & (K Doses)
Table 34. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country/Region (2019-2024)
Table 35. Global Point-Of-Care Or Rapid Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas Point-Of-Care Or Rapid Diagnostics Sales by Country (2019-2024) & (K Doses)
Table 38. Americas Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2019-2024)
Table 39. Americas Point-Of-Care Or Rapid Diagnostics Revenue by Country (2019-2024) & ($ Millions)
Table 40. Americas Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2019-2024)
Table 41. Americas Point-Of-Care Or Rapid Diagnostics Sales by Type (2019-2024) & (K Doses)
Table 42. Americas Point-Of-Care Or Rapid Diagnostics Sales by Application (2019-2024) & (K Doses)
Table 43. APAC Point-Of-Care Or Rapid Diagnostics Sales by Region (2019-2024) & (K Doses)
Table 44. APAC Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region (2019-2024)
Table 45. APAC Point-Of-Care Or Rapid Diagnostics Revenue by Region (2019-2024) & ($ Millions)
Table 46. APAC Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Region (2019-2024)
Table 47. APAC Point-Of-Care Or Rapid Diagnostics Sales by Type (2019-2024) & (K Doses)
Table 48. APAC Point-Of-Care Or Rapid Diagnostics Sales by Application (2019-2024) & (K Doses)
Table 49. Europe Point-Of-Care Or Rapid Diagnostics Sales by Country (2019-2024) & (K Doses)
Table 50. Europe Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2019-2024)
Table 51. Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country (2019-2024) & ($ Millions)
Table 52. Europe Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2019-2024)
Table 53. Europe Point-Of-Care Or Rapid Diagnostics Sales by Type (2019-2024) & (K Doses)
Table 54. Europe Point-Of-Care Or Rapid Diagnostics Sales by Application (2019-2024) & (K Doses)
Table 55. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Country (2019-2024) & (K Doses)
Table 56. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2019-2024)
Table 57. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country (2019-2024) & ($ Millions)
Table 58. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2019-2024)
Table 59. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Type (2019-2024) & (K Doses)
Table 60. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Application (2019-2024) & (K Doses)
Table 61. Key Market Drivers & Growth Opportunities of Point-Of-Care Or Rapid Diagnostics
Table 62. Key Market Challenges & Risks of Point-Of-Care Or Rapid Diagnostics
Table 63. Key Industry Trends of Point-Of-Care Or Rapid Diagnostics
Table 64. Point-Of-Care Or Rapid Diagnostics Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Point-Of-Care Or Rapid Diagnostics Distributors List
Table 67. Point-Of-Care Or Rapid Diagnostics Customer List
Table 68. Global Point-Of-Care Or Rapid Diagnostics Sales Forecast by Region (2025-2030) & (K Doses)
Table 69. Global Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Americas Point-Of-Care Or Rapid Diagnostics Sales Forecast by Country (2025-2030) & (K Doses)
Table 71. Americas Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. APAC Point-Of-Care Or Rapid Diagnostics Sales Forecast by Region (2025-2030) & (K Doses)
Table 73. APAC Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Region (2025-2030) & ($ millions)
Table 74. Europe Point-Of-Care Or Rapid Diagnostics Sales Forecast by Country (2025-2030) & (K Doses)
Table 75. Europe Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales Forecast by Country (2025-2030) & (K Doses)
Table 77. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 78. Global Point-Of-Care Or Rapid Diagnostics Sales Forecast by Type (2025-2030) & (K Doses)
Table 79. Global Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 80. Global Point-Of-Care Or Rapid Diagnostics Sales Forecast by Application (2025-2030) & (K Doses)
Table 81. Global Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 82. Roche Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 83. Roche Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
Table 84. Roche Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. Roche Main Business
Table 86. Roche Latest Developments
Table 87. Abbott Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 88. Abbott Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
Table 89. Abbott Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 90. Abbott Main Business
Table 91. Abbott Latest Developments
Table 92. Danaher Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 93. Danaher Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
Table 94. Danaher Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 95. Danaher Main Business
Table 96. Danaher Latest Developments
Table 97. Siemens Healthcare Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 98. Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
Table 99. Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 100. Siemens Healthcare Main Business
Table 101. Siemens Healthcare Latest Developments
Table 102. Bio-Rad Laboratories Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 103. Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
Table 104. Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 105. Bio-Rad Laboratories Main Business
Table 106. Bio-Rad Laboratories Latest Developments
Table 107. BioMerieux Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 108. BioMerieux Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
Table 109. BioMerieux Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 110. BioMerieux Main Business
Table 111. BioMerieux Latest Developments
Table 112. Nova Biomedical Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 113. Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
Table 114. Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 115. Nova Biomedical Main Business
Table 116. Nova Biomedical Latest Developments
Table 117. Thermo Fisher Scientific Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 118. Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
Table 119. Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 120. Thermo Fisher Scientific Main Business
Table 121. Thermo Fisher Scientific Latest Developments
Table 122. Quidel Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 123. Quidel Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
Table 124. Quidel Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 125. Quidel Main Business
Table 126. Quidel Latest Developments
Table 127. A. Menarini Diagnostics Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 128. A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
Table 129. A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 130. A. Menarini Diagnostics Main Business
Table 131. A. Menarini Diagnostics Latest Developments
Table 132. Becton Dickinson Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 133. Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
Table 134. Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 135. Becton Dickinson Main Business
Table 136. Becton Dickinson Latest Developments
Table 137. Biosurfit Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 138. Biosurfit Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
Table 139. Biosurfit Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 140. Biosurfit Main Business
Table 141. Biosurfit Latest Developments
Table 142. Astrego Diagnostics Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 143. Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
Table 144. Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 145. Astrego Diagnostics Main Business
Table 146. Astrego Diagnostics Latest Developments
Table 147. Werfen Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 148. Werfen Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
Table 149. Werfen Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 150. Werfen Main Business
Table 151. Werfen Latest Developments
Table 152. Abionic Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 153. Abionic Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
Table 154. Abionic Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 155. Abionic Main Business
Table 156. Abionic Latest Developments
Table 157. Palex Medical/Bülhmann Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 158. Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
Table 159. Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 160. Palex Medical/Bülhmann Main Business
Table 161. Palex Medical/Bülhmann Latest Developments
Table 162. Horiba Medical Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 163. Horiba Medical Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
Table 164. Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 165. Horiba Medical Main Business
Table 166. Horiba Medical Latest Developments
Table 167. RAL Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 168. RAL Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
Table 169. RAL Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 170. RAL Main Business
Table 171. RAL Latest Developments
Table 172. Vircell Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 173. Vircell Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
Table 174. Vircell Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 175. Vircell Main Business
Table 176. Vircell Latest Developments
Table 177. Monlab Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 178. Monlab Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
Table 179. Monlab Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 180. Monlab Main Business
Table 181. Monlab Latest Developments
Table 182. Binding Site Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 183. Binding Site Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
Table 184. Binding Site Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 185. Binding Site Main Business
Table 186. Binding Site Latest Developments

Logo

Global Point-Of-Care Or Rapid Diagnostics Market Growth 2024-2030

Contact usWe are friendly and approachable, give us a call.